These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33737450)

  • 1. Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis.
    Yamada S; Hashizume A; Hijikata Y; Ito D; Kishimoto Y; Iida M; Koike H; Hirakawa A; Katsuno M
    J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1072-1079. PubMed ID: 33737450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
    Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
    Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary p75
    Shepheard SR; Wuu J; Cardoso M; Wiklendt L; Dinning PG; Chataway T; Schultz D; Benatar M; Rogers ML
    Neurology; 2017 Mar; 88(12):1137-1143. PubMed ID: 28228570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
    Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.
    Shepheard SR; Karnaros V; Benyamin B; Schultz DW; Dubowsky M; Wuu J; Chataway T; Malaspina A; Benatar M; Rogers ML
    Eur J Neurol; 2022 Apr; 29(4):990-999. PubMed ID: 34967083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
    Thouvenot E; Demattei C; Lehmann S; Maceski-Maleska A; Hirtz C; Juntas-Morales R; Pageot N; Esselin F; Alphandéry S; Vincent T; Camu W
    Eur J Neurol; 2020 Feb; 27(2):251-257. PubMed ID: 31437330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.
    Witzel S; Frauhammer F; Steinacker P; Devos D; Pradat PF; Meininger V; Halbgebauer S; Oeckl P; Schuster J; Anders S; Dorst J; Otto M; Ludolph AC
    Transl Neurodegener; 2021 Aug; 10(1):31. PubMed ID: 34433481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary titin N-fragment as a predictor of decreased skeletal muscle mass in patients with interstitial lung diseases.
    Hanada M; Ishimatsu Y; Sakamoto N; Akiyama Y; Kido T; Ishimoto H; Oikawa M; Nagura H; Takeuchi R; Sato S; Takahata H; Mukae H; Kozu R
    Sci Rep; 2023 Jun; 13(1):9723. PubMed ID: 37322176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.
    Verde F; Steinacker P; Weishaupt JH; Kassubek J; Oeckl P; Halbgebauer S; Tumani H; von Arnim CAF; Dorst J; Feneberg E; Mayer B; Müller HP; Gorges M; Rosenbohm A; Volk AE; Silani V; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):157-164. PubMed ID: 30309882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Urinary N-Terminal Fragment of Titin to Predict Mortality in Dilated Cardiomyopathy.
    Yoshihisa A; Kimishima Y; Kiko T; Sato Y; Watanabe S; Kanno Y; Abe S; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Am J Cardiol; 2018 May; 121(10):1260-1265. PubMed ID: 29523227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis.
    Falzone YM; Domi T; Mandelli A; Pozzi L; Schito P; Russo T; Barbieri A; Fazio R; Volontè MA; Magnani G; Del Carro U; Carrera P; Malaspina A; Agosta F; Quattrini A; Furlan R; Filippi M; Riva N
    Eur J Neurol; 2022 Jul; 29(7):1930-1939. PubMed ID: 35263489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
    Gaiottino J; Norgren N; Dobson R; Topping J; Nissim A; Malaspina A; Bestwick JP; Monsch AU; Regeniter A; Lindberg RL; Kappos L; Leppert D; Petzold A; Giovannoni G; Kuhle J
    PLoS One; 2013; 8(9):e75091. PubMed ID: 24073237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis.
    Shepheard SR; Chataway T; Schultz DW; Rush RA; Rogers ML
    PLoS One; 2014; 9(1):e87398. PubMed ID: 24475283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics.
    Kojima Y; Kasai T; Noto YI; Ohmichi T; Tatebe H; Kitaoji T; Tsuji Y; Kitani-Morii F; Shinomoto M; Allsop D; Teramukai S; Mizuno T; Tokuda T
    PLoS One; 2021; 16(11):e0260323. PubMed ID: 34843548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study.
    Li JY; Dai Y; Sun XH; Ren HT; Shen DC; Yang XZ; Liu MS; Cui LY
    Brain Behav; 2023 May; 13(5):e2997. PubMed ID: 37070132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.
    Steinacker P; Huss A; Mayer B; Grehl T; Grosskreutz J; Borck G; Kuhle J; Lulé D; Meyer T; Oeckl P; Petri S; Weishaupt J; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):112-119. PubMed ID: 27819158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.